(Q34086310)

30 July 2017

1 reference

title

Cardiogenic shock complicating acute coronary syndromes (English)

1 reference

30 July 2017

1 reference

acute coronary syndrome

1 reference

2

E J Topol

1 reference

30 July 2017

3

R M Califf

1 reference

30 July 2017

D Hasdai

1

1 reference

30 July 2017

P B Berger

series ordinal

4

1 reference

30 July 2017

D R Holmes

series ordinal

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

356

1 reference

30 July 2017

9231

1 reference

30 July 2017

749-756

1 reference

Recent trends in hospital mortality of acute myocardial infarction--the Worcester Heart Attack Study. Have improvements been realized for all age groups?

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Temporal trends in cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Prognosis in cardiogenic shock after acute myocardial infarction in the intervencional era

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Usefulness of coronary stenting for cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) tria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Clinical and hemodynamic results of intraortic balloon counterpulsation and surgery for cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Elderly patients at highest risk with acute myocardial infarction are more frequently transferred from community hospitals to tertiary centers: reality or myth?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

Insulin and glucose in treatment of cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902640-4

7 January 2021

10.1016/S0140-6736(00)02640-4

Identifiers

DOI

1 reference

30 July 2017

1 reference